Liquid chromatography–tandem mass spectrometry (LC–MS/MS) reveals distinct sphingolipid patterns in anorexia and obesity.
|Articles|May 1, 2018
- LCGC Europe-05-01-2018
- Volume 31
- Issue 5
Vol 31 No 5 LCGC Europe May 2018 Regular Issue PDF
Click the title above to open the LCGC Europe May 2018 regular issue, Vol 31, No 5, in an interactive PDF format.
Advertisement
Articles in this issue
over 8 years ago
Biomimetic Chromatography to Accelerate Drug Discovery: Part 2over 8 years ago
New Sample Preparation Products and Accessoriesover 8 years ago
New Gas Chromatography Products for 2017–2018over 8 years ago
The 2018 LCGC Awardsover 8 years ago
A Step-by-Step Guide to Inlet Maintenanceover 8 years ago
2018 Sample Prep Summer Courseover 8 years ago
Quantifying Aquatic Toxins Using UHPLC–MS/MSAdvertisement
Related to this article
Leon Niezen and Gert Desmet discuss uncertainty-driven LC method development, peak overlap, and moving from in silico to real data.
Leon Niezen and Gert Desmet describe how predictive uncertainty can make automated LC method development more reliable.
Liquid chromatography–mass spectrometry (LC–MS) serum profiling ties lysine compounds to lupus kidney disease.
Liquid chromatography-mass spectrometry (LC–MS) growth lifts Waters Q3; MOBILion ion mobility buy expands proteomics.
Liquid chromatography–tandem mass spectrometry (LC–MS/MS) measures galactose-1-phosphate in dried blood spots to monitor galactosemia.
Sam Whitmarsh explores how retention-time models handle interlaboratory data, novel chemotypes, unusual phases and ionisable compounds, and what labs need to do to build useful in-house models.
Advertisement
Advertisement
Trending on LCGC International
1
AI/ML Now: Toxicity Prediction for Unknown LC–HRMS Features Using Machine Learning
2
LCGC Blog: Building a Career Series That Goes Beyond the Surface
3
Industry Roundup: Waters Posts Strong Third Quarter as LC–MS and Chromatography Consumables Drive Growth, Acquires Ion Mobility Pioneer MOBILion
4
From 9000 Clues to a Clinical Test: Mass Spectrometry-Driven Lipidomics for Early Cancer Detection
5